Intravenous Medicine
Infusion & immune therapies
Our infusion service brings together medicines, nutrient preparations and immune therapies within an individual treatment plan. Options include artesunate, curcumin IV, high-dose vitamin C and amino acid infusions. Your physician decides what is relevant to your diagnosis and current care.
Infusion & immune
Treatments in this group
- TherapyImmune therapy
Immune therapy at St. George Hospital means thymus peptides, mistletoe extract (Viscum album) and, in selected patients, dendritic cell preparations made from your …
- TherapyVitamin drips
High-dose intravenous vitamin C and individually selected nutrient infusions are available at St. George Hospital.
- TherapyNAD+ IV
A slow intravenous infusion of nicotinamide adenine dinucleotide (NAD+), the coenzyme every cell uses to make energy and repair DNA, given on our ward over 2–4 …
- TherapyMethylene blue IV
A slow intravenous infusion of pharmaceutical-grade methylene blue at a low, physician-set dose, given on our ward as one module of a plan for chronic infections …
- TherapyArtesunate IV
St. George Hospital offers intravenous artesunate within individually assessed cancer and chronic-infection treatment plans.
- TherapyCurcumin IV
Intravenous curcumin is available at St. George Hospital as a possible component of an individual treatment plan.
- TherapyAmino-acid infusions
St. George Hospital offers individually selected amino acid infusions, sometimes called amino acid cocktails.
Infusions selected for your situation
An infusion delivers a preparation into a vein. The clinical question comes first: what is being treated, why this substance and route are proposed, and how the result will be assessed. Different preparations have different uses, interactions and monitoring requirements.
At St. George Hospital, the available options include artesunate for individually assessed cancer and chronic-infection plans, curcumin IV, high-dose vitamin C and amino acid infusions. They are considered alongside the other elements of your programme.
Explore our infusion options
Artesunate IV
- What it is
- An intravenously administered medicine
- Where the discussion starts
- Selected cancer and chronic-infection treatment plans
- Read more
- Clinical context, research and monitoring
Curcumin IV
- What it is
- An intravenous curcumin preparation
- Where the discussion starts
- The diagnosis, exact formulation and accompanying treatment
- Read more
- Preparation-specific studies and safety
High-dose vitamin C
- What it is
- Intravenous vitamin C and selected nutrient formulations
- Where the discussion starts
- The treatment goal, kidney history, G6PD status and medicines
- Read more
- Vitamin C research and infusion planning
Amino acid infusions
- What it is
- Individually selected protein building blocks
- Where the discussion starts
- Nutritional needs, food intake and medical assessment
- Read more
- How nutritional support is assessed
Availability is separate from suitability. The consultation establishes the reason for each proposed infusion.
Other infusion and immune therapies
Immune therapyExplore the immune therapies considered within individual programmes.
NAD+ IVThe intravenous route, clinical assessment and research context.
Methylene blue IVThe proposed role, medication interactions and safety review.
How your infusion plan is made
Review
Your physician considers the diagnosis, current treatment, medicines and relevant test results.
Discuss
Agree on the purpose of the proposed preparation, alternatives and monitoring.
Treat and reassess
The team monitors the infusion and reviews tolerability and progress before further treatment.
Research and the treatment decision
Research needs to match the preparation and diagnosis. Examples include an early safety study of IV artesunate in solid tumours, a trial of one curcumin preparation with paclitaxel in breast cancer and a small randomized vitamin C study alongside chemotherapy in pancreatic cancer. These studies answer different questions; they are not evidence that every infusion works across all conditions.
The individual therapy pages explain these findings and relevant risks. For amino acid infusions, the starting point is nutritional assessment, reflected in the ESPEN clinical nutrition guideline. Your consultation brings the available research together with your medical history, goals and current care.
Where infusion assessment fits
- Integrative oncology
Coordinate any proposed infusion with your existing oncology care.
- Chronic Lyme disease
Assess options within a wider plan for diagnosis and persistent symptoms.
- Long COVID and ME/CFS
Review the individual clinical question and relevant findings.
- Longevity
Discuss nutritional and medical needs within your health assessment.
Costs and your first inquiry
The proposed infusion plan is explained after medical review. The written cost overview identifies the relevant treatment components before you decide about a stay.
Start with a short message to the International Office. It explains how to share your records securely for medical assessment; you do not need to select a particular infusion yourself.
Frequently asked questions
Are all infusions included in every programme?
No. The list describes available options. Your physician selects the preparation, if appropriate, for your diagnosis and findings.
Is an infusion always better than taking a medicine or nutrient orally?
No. The route depends on the substance and the clinical reason. An infusion can change exposure, but that alone does not establish a clinical benefit.
Can I combine infusions with my current cancer treatment?
The team reviews your current treatment and medicines before making a recommendation. Timing, interactions and monitoring need to be coordinated with your oncology care.
How are costs explained?
After medical review, the written cost overview identifies the proposed treatment components. The formulation, number of sessions and wider programme affect the estimate.
References
- A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies. Cancer Chemotherapy and Pharmacology 2018. PMID 29392450
- Efficacy and safety of curcumin in combination with paclitaxel in patients with advanced, metastatic breast cancer. Phytomedicine 2020. PMID 32335356
- A randomized trial of pharmacological ascorbate, gemcitabine, and nab-paclitaxel for metastatic pancreatic cancer. Redox Biology 2024. PMID 39369582
- ESPEN practical guideline: Clinical Nutrition in cancer. Clinical Nutrition 2021. PMID 33946039
From the journal
Reading on Detox, ozone and IV therapies
- Vitamin C · · 6 min read
High-Dose vitamin C IV for cancer: Mechanism, evidence, and clinical application
When most people think of vitamin C, they think of orange juice and cold prevention. But at pharmacological doses — 25 to 100 grams or more administered intravenously — vitamin C behaves in a fundamentally different way. Rather than acting as the antioxidant it is
- Glutathione · · 7 min read
IV glutathione benefits: The master antioxidant in detoxification and brain health research
Glutathione is a tripeptide molecule composed of three amino acids — glutamine, cysteine, and glycine — found in virtually every cell of the human body. Often called the “master antioxidant,” glutathione plays an indispensable role in neutralizing free radicals, supporting liver detoxification,…
- NAD+ · · 8 min read
NAD+ IV therapy: Benefits, cost, side effects, and what to expect
Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell, essential for hundreds of metabolic processes including energy production, DNA repair, cellular signaling, and gene expression. As we age — and during chronic illness — NAD+ levels decline significantly,…
Send a free inquiry
The initial inquiry is free of charge. The International Office reviews your message and your case directly and gets back to you.
- Phone
- +49 8061 398-0
- Hours
- Mon–Thu 08:00–17:00, Fri 08:00–14:00 German time (CET/CEST); in the US Mon–Thu 2–11 a.m. ET, Fri 2–8 a.m. ET.
Munich Airport (MUC), about 60 minutes by car.